Nanoparticle gene editing restores CFTR function in cystic fibrosis lab model
Researchers developed a lipid nanoparticle gene-editing approach that inserted a full CFTR gene into airway cells and restored 88% to 100% of normal channel function in a cystic fibrosis lab model.